Search

everythinglearnresearchcommunity

for

Search:↓

A 23-year-old woman's missed periods were caused by a rare genetic disorder treated with hormone patches.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The 18-year-old girl likely has a condition called müllerian agenesis, which caused her to not have a uterus and experience no menstrual periods.

DNMT1 helps turn hair follicle stem cells into fat cells by blocking a specific microRNA.

Exposure to finasteride in the womb caused lasting reproductive issues in male rats.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

DHEA stimulates skin oil glands and could help postmenopausal women, with potential for acne and excessive hair growth treatments.

The right dosage of CPA and TB can work as a safe and reversible male contraceptive in monkeys.

Iron deficiency is not a significant cause of hair loss in women.

Hair loss in men is common, treatable, but not curable.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Eating too much selenium can cause bad breath, hair loss, and nail changes, with harmful effects starting at low daily doses.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

Men with low or no sperm count have lower salivary testosterone levels, and saliva testing can measure their testosterone well.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

A man with both Klinefelter syndrome and primary hyperparathyroidism showed a rare combination of symptoms and genetic patterns.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Higher BMI and lower testosterone are linked to more aggressive prostate cancer.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.